Clinical Trials

Dose Escalation Study to Determine Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TKM-080301

Location:

, Scottsdale and Phoenix, AZ

Trial status:

Open for Enrollment

Why is this study being done?

This study will be a Phase I, open-label, non-randomized, dose-finding trial conducted at multiple clinical centers. The study is designed to determine the safety, tolerability and PK of TKM-080301 in adult patients with solid tumors or lymphomas that are refractory to standard therapy or for whom there is no standard therapy.

Last updated: 09/26/2012

NCT ID:

NCT01262235